Cargando…

Comparison of gemcitabine and anthracycline antibiotics in prevention of superficial bladder cancer recurrence

BACKGROUND: Because of the failure, shortage and related toxicities of Bacillus Calmette-Guérin (BCG), the other intravesical chemotherapy drugs are also widely used in clinical application. Gemcitabine and anthracycline antibiotics (epirubicin and pirarubicin) are widely used as first-line or salva...

Descripción completa

Detalles Bibliográficos
Autores principales:	Wang, Tian-Wei, Yuan, Hui, Diao, Wen-Li, Yang, Rong, Zhao, Xiao-Zhi, Guo, Hong-Qian
Formato:	Online Artículo Texto
Lenguaje:	English
Publicado:	BioMed Central 2019
Materias:	Research Article
Acceso en línea:	https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6794870/ https://www.ncbi.nlm.nih.gov/pubmed/31615492 http://dx.doi.org/10.1186/s12894-019-0530-0

Ejemplares similares

Natural History, Recurrence, and Progression in Superficial Bladder Cancer
por: Sylvester, Richard J.
Publicado: (2006)

Management of BCG non-responders with fixed dose intravesical gemcitabine in superficial transitional cell carcinoma of urinary bladder
por: Mohanty, N. K., et al.
Publicado: (2008)

A chemical perspective on the anthracycline antitumor antibiotics.
por: Abdella, B R, et al.
Publicado: (1985)

Radiation Sterilization of Anthracycline Antibiotics in Solid State
por: Kaczmarek, A., et al.
Publicado: (2013)

Gemcitabine hydrochloride microspheres used for intravesical treatment of superficial bladder cancer: a comprehensive in vitro/ex vivo/in vivo evaluation
por: Karavana, Sinem Yaprak, et al.
Publicado: (2018)

Design and evaluation of an intravesical delivery system for superficial bladder cancer: preparation of gemcitabine HCl-loaded chitosan–thioglycolic acid nanoparticles and comparison of chitosan/poloxamer gels as carriers
por: Ay Şenyiğit, Zeynep, et al.
Publicado: (2015)

Overexpression of cyclin D1 correlates with early recurrence in superficial bladder cancers.
por: Shin, K. Y., et al.
Publicado: (1997)

Gemcitabine in Recurrent Meningioma
por: Khaddar, Satvik, et al.
Publicado: (2020)

Editorial: Superficial Bladder Cancer
por: Kirkali, Ziya
Publicado: (2006)

Superficial Bladder Cancer Therapy
por: Schenkman, Emmanuel, et al.
Publicado: (2004)

Phase I trial of intravesical Suramin in recurrent superficial transitional cell bladder carcinoma
por: Ord, J J, et al.
Publicado: (2005)

Vitamin E Reduces Superficial Bladder Cancer Recurrence: A Randomized Controlled Trial
por: Mazdak, Hamid, et al.
Publicado: (2012)

Comparison of 3 and 4 cycles of neoadjuvant gemcitabine and cisplatin for muscle-invasive bladder cancer: a systematic review and meta-analysis
por: Lu, Lanpeng, et al.
Publicado: (2023)

Clinical efficacy of intravesical gemcitabine combined with ubenimex in patients with non-muscle-invasive bladder carcinoma after transurethral resection of bladder tumor
por: Shao, Li-jun, et al.
Publicado: (2022)

Anthracycline antibiotics derivate mitoxantrone—Destructive sorption and photocatalytic degradation
por: Štenglová-Netíková, Irena R., et al.
Publicado: (2018)

Pathophysiology and preventive strategies of anthracycline-induced cardiotoxicity
por: Chung, Woo-Baek, et al.
Publicado: (2016)

Neprilysin Inhibition in the Prevention of Anthracycline-Induced Cardiotoxicity
por: Sobiborowicz-Sadowska, Aleksandra M., et al.
Publicado: (2023)

Metformin to Prevent Anthracycline Cardiotoxicity?: That Would Be Sweet!
por: El-Rayes, Malak, et al.
Publicado: (2023)

Development and Validation of a Diagnostic Nomogram to Predict the Anthracycline-Induced Early Cardiotoxicity in Children with Hematological Tumors
por: Liu, Zhi-yuan, et al.
Publicado: (2022)

Outcomes of Palliative Weekly Low-Dose Gemcitabine-Cisplatin Chemotherapy in Anthracycline- and Taxane- Pretreated Metastatic Breast Cancer Patients
por: Kim, Jung Sun, et al.
Publicado: (2014)

In vitro synergistic cytotoxicity of gemcitabine and pemetrexed and pharmacogenetic evaluation of response to gemcitabine in bladder cancer patients
por: Mey, V, et al.
Publicado: (2006)

Endoscopic Ultrasonic Aspiration of Superficial Bladder Tumors
por: Miki, Makoto, et al.
Publicado: (1995)

Squamous differentiation in patients with superficial bladder urothelial carcinoma is associated with high risk of recurrence and poor survival
por: Li, Gang, et al.
Publicado: (2017)

Evaluation of Apoptosis in Multipotent Hematopoietic Cells of Bone Marrow by Anthracycline Antibiotics
por: Aramvash, Asieh, et al.
Publicado: (2017)

Mutations of p53 decrease sensitivity to the anthracycline treatments in bladder cancer cells
por: Pandey, Sony, et al.
Publicado: (2018)

Dexrazoxane for Preventing Anthracycline Cardiotoxicity in Children with Solid Tumors
por: Choi, Hyoung Soo, et al.
Publicado: (2010)

Strategies to prevent anthracycline-induced cardiotoxicity in cancer survivors
por: Bansal, Neha, et al.
Publicado: (2019)

Harnessing Genomics to Predict and Prevent Anthracycline-Associated Cardiotoxicity
por: Sapkota, Yadav
Publicado: (2020)

Efficacy of Dexrazoxane in Preventing Anthracycline Cardiotoxicity in Breast Cancer
por: Macedo, Ariane V.S., et al.
Publicado: (2019)

Comparison between neoadjuvant and adjuvant gemcitabine plus cisplatin chemotherapy for muscle-invasive bladder cancer
por: Matsubara, Nobuaki, et al.
Publicado: (2013)

Bioinformatics analysis of prognosis and immune microenvironment of immunological cell death-related gemcitabine-resistance genes in bladder cancer
por: Liu, Chao, et al.
Publicado: (2022)

Cardiotoxicity of Anthracyclines
por: Cardinale, Daniela, et al.
Publicado: (2020)

Risk Factors for Anthracycline-Induced Cardiotoxicity
por: Qiu, Shuo, et al.
Publicado: (2021)

Circular RNA CircHIPK3 Promotes Gemcitabine Sensitivity in Bladder Cancer
por: Xie, Fang, et al.
Publicado: (2020)

Bacillus Calmette-Guérin in the management of superficial bladder cancer
por: Kapoor, Rakesh, et al.
Publicado: (2008)

Best Approach for Low-Risk Superficial Bladder Cancer
por: Solsona, Eduardo
Publicado: (2006)

Publication of a Special Issue: Superficial Bladder Cancer
por: Redhead, Claire
Publicado: (2006)

Formulation and characterization of EGCG for the treatment of superficial bladder cancer
por: Dettlaff, Katarzyna, et al.
Publicado: (2017)

Anthracycline-based and gemcitabine-based chemotherapy in the adjuvant setting for stage I uterine leiomyosarcoma: a retrospective analysis at two reference centers
por: Fucà, Giovanni, et al.
Publicado: (2020)

Ellagic Acid Resensitizes Gemcitabine-Resistant Bladder Cancer Cells by Inhibiting Epithelial-Mesenchymal Transition and Gemcitabine Transporters
por: Wu, Ying-Si, et al.
Publicado: (2021)

Cannot write session to /tmp/vufind_sessions/sess_4039mabs83kh8id0dj63h4ihkd